0.68 - 0.75
0.33 - 0.86
12.91M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
16.70%
Revenue growth above 1.5x 0425.HK's 3.73%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
15.77%
Gross profit growth above 1.5x 0425.HK's 2.78%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
105.96%
EBIT growth above 1.5x 0425.HK's 4.51%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
105.96%
Operating income growth above 1.5x 0425.HK's 4.51%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
322.84%
Net income growth above 1.5x 0425.HK's 19.04%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
330.00%
EPS growth above 1.5x 0425.HK's 18.60%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
344.83%
Diluted EPS growth above 1.5x 0425.HK's 18.60%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-1.33%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-5.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
120.51%
OCF growth above 1.5x 0425.HK's 17.42%. David Dodd would confirm a clear edge in underlying cash generation.
276.82%
Positive FCF growth while 0425.HK is negative. John Neff would see a strong competitive edge in net cash generation.
87778.82%
10Y revenue/share CAGR above 1.5x 0425.HK's 640.87%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
13.18%
5Y revenue/share CAGR under 50% of 0425.HK's 115.89%. Michael Burry would suspect a significant competitive gap or product weakness.
40.90%
3Y revenue/share CAGR at 50-75% of 0425.HK's 59.46%. Martin Whitman would question if the firm lags behind competitor innovations.
4300.92%
10Y OCF/share CAGR above 1.5x 0425.HK's 844.40%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
1020.89%
5Y OCF/share CAGR above 1.5x 0425.HK's 29.03%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
4574.68%
3Y OCF/share CAGR above 1.5x 0425.HK's 6.27%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
660.42%
Net income/share CAGR above 1.5x 0425.HK's 323.92% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-48.70%
Negative 5Y net income/share CAGR while 0425.HK is 48.83%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-43.92%
Negative 3Y CAGR while 0425.HK is 33.83%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
538.69%
5Y equity/share CAGR above 1.5x 0425.HK's 95.75%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
104.48%
3Y equity/share CAGR above 1.5x 0425.HK's 32.59%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
-91.11%
Negative 5Y dividend/share CAGR while 0425.HK stands at 441.43%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
46.46%
Below 50% of 0425.HK's 225.06%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
3.48%
Our AR growth while 0425.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
21.91%
Inventory growth well above 0425.HK's 21.10%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.59%
Asset growth well under 50% of 0425.HK's 5.22%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
18.28%
BV/share growth above 1.5x 0425.HK's 3.35%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.26%
We’re deleveraging while 0425.HK stands at 17.59%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
314.74%
We increase R&D while 0425.HK cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
4.92%
SG&A growth well above 0425.HK's 2.20%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.